We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
Cap. Flow
-$115M
Cap. Flow %
-0.27%
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$189M
2
WMB icon
Williams Companies
WMB
+$155M
3
AYX
Alteryx Inc
AYX
+$94.1M
4
ABBV icon
AbbVie
ABBV
+$87M
5
AMGN icon
Amgen
AMGN
+$78.1M

Sector Composition

Rank Sector Weight
1 Technology 17.44%
2 Healthcare 17.1%
3 Financials 12.78%
4 Industrials 10.38%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ODFL icon
351
Old Dominion Freight Line
ODFL
$37.7B
$26.9M 0.06%
122,520
+31,420
+34% +$6.55M
WFRD icon
352
Weatherford International
WFRD
$6.04B
$26.7M 0.06%
231,107
-216,042
-48% -$21.9M
WCC
353
WESCO International
WCC
$16.4B
$26.5M 0.06%
154,749
+58,927
+61% +$9.74M
SKYW icon
354
Skywest
SKYW
$3.73B
$26.4M 0.06%
382,452
-7,378
-2% -$437K
CNP icon
355
CenterPoint Energy
CNP
$25.8B
$26.1M 0.06%
916,064
-65,049
-7% -$1.82M
CHX
356
DELISTED
ChampionX
CHX
$26M 0.06%
725,730
+115,074
+19% +$3.44M
IT icon
357
Gartner
IT
$12.4B
$26M 0.06%
54,506
+6,693
+14% +$3.08M
RZLT icon
358
Rezolute
RZLT
$409M
$25.9M 0.06%
10,154,327
MRO
359
DELISTED
Marathon Oil Corporation
MRO
$25.9M 0.06%
912,419
+5,408
+0.6% +$130K
AZO icon
360
AutoZone
AZO
$47B
$25.8M 0.06%
8,190
+462
+6% +$1.32M
BSX icon
361
Boston Scientific
BSX
$65.3B
$25.8M 0.06%
376,765
+194,895
+107% +$12.5M
DOC icon
362
Healthpeak Properties
DOC
$14B
$25.7M 0.06%
1,371,484
+1,367,763
+36,758% +$24.9M
CHH icon
363
Choice Hotels
CHH
$4.36B
$25.5M 0.06%
201,593
-101,563
-34% -$12.1M
LAZ icon
364
Lazard
LAZ
$4.01B
$25.4M 0.06%
+607,370
New +$23.7M
PGR icon
365
Progressive
PGR
$126B
$25.3M 0.06%
122,451
+23,051
+23% +$4.28M
RYAN icon
366
Ryan Specialty Holdings
RYAN
$4.65B
$25.1M 0.06%
451,720
+343,374
+317% +$16.4M
DCBO
367
Docebo
DCBO
$605M
$25.1M 0.06%
511,660
-37,789
-7% -$1.81M
ELV icon
368
Elevance Health
ELV
$90.8B
$25M 0.06%
48,306
+5,644
+13% +$2.81M
IBM icon
369
IBM
IBM
$235B
$25M 0.06%
131,159
-16,334
-11% -$2.98M
ROST icon
370
Ross Stores
ROST
$73.7B
$24.8M 0.06%
168,998
+4,122
+3% +$591K
SUM
371
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$24.7M 0.06%
554,079
+322,685
+139% +$12.8M
POWI icon
372
Power Integrations
POWI
$2.92B
$24.6M 0.06%
344,335
+33,325
+11% +$2.49M
SNX icon
373
TD Synnex
SNX
$20.9B
$24.6M 0.06%
217,550
-9,495
-4% -$986K
HIG icon
374
Hartford Financial Services
HIG
$36.9B
$24.6M 0.06%
238,664
-134,819
-36% -$12.4M
KKR icon
375
KKR & Co
KKR
$90.7B
$24.6M 0.06%
244,108
+126,503
+108% +$11.6M

Similar funds

Federated Hermes's Q1 2024 Portfolio in Review

As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
  • Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
  • Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
  • Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
  • Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.